Journal of clinical laboratory analysis · 2025
Predictive Role of Hematological Biomarkers in Chronic Kidney Disease Progression.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ogolla Collince Odiwuor, Karani Lucy W, Musyoki Stanslaus, Maruti Phidelis
Аннотация
BACKGROUND: Chronic kidney disease is a progressive disorder of the body with high morbidity. Hematological biomarkers can predict CKD progression.
OBJECTIVE: This study examined the predictive role of hematological parameters among adult CKD patients.
METHODS: The records of 120 adult patients with CKD were retrieved. CKD staging was according to KDIGO guidelines. Hematological parameters were hemoglobin, WBC, percentages of neutrophils and lymphocytes, NLR, platelet count, MCV, and RDW. Data were analyzed to assess associations between hematological markers and disease stage.
RESULTS: Mean age was 56.4 ± 13.2 years, with 56.7% being male. Prevalence was 65.0% for hypertension and 38.3% for diabetes mellitus. There was a significant decrease in hemoglobin with CKD stage (13.4 ± 1.1 g/dL in Stage 1 to 8.5 ± 1.7 g/dL in Stage 5, p < 0.001), while NLR and RDW increased progressively with CKD stage (NLR: 1.55 ± 0.48 to 4.12 ± 1.02; RDW: 13.1% ± 0.8% to 16.0% ± 1.6%, both p < 0.001). Anemia and raised NLR were more frequent in the advanced stages of CKD. Logistic regression analysis identified hemoglobin (OR = 0.69, 95% CI: 0.58-0.82, p < 0.001), RDW (OR = 1.78, 95% CI: 1.33-2.39, p = 0.002), and NLR (OR = 1.91, 95% CI: 1.35-2.72, p = 0.001) as independent predictors of advanced CKD. These simple and inexpensive biomarkers are particularly valuable in resource-limited settings.
CONCLUSION: Hematological biomarkers, especially hemoglobin, NLR, and RDW, were effectively used to predict the progression of CKD.
OBJECTIVE: This study examined the predictive role of hematological parameters among adult CKD patients.
METHODS: The records of 120 adult patients with CKD were retrieved. CKD staging was according to KDIGO guidelines. Hematological parameters were hemoglobin, WBC, percentages of neutrophils and lymphocytes, NLR, platelet count, MCV, and RDW. Data were analyzed to assess associations between hematological markers and disease stage.
RESULTS: Mean age was 56.4 ± 13.2 years, with 56.7% being male. Prevalence was 65.0% for hypertension and 38.3% for diabetes mellitus. There was a significant decrease in hemoglobin with CKD stage (13.4 ± 1.1 g/dL in Stage 1 to 8.5 ± 1.7 g/dL in Stage 5, p < 0.001), while NLR and RDW increased progressively with CKD stage (NLR: 1.55 ± 0.48 to 4.12 ± 1.02; RDW: 13.1% ± 0.8% to 16.0% ± 1.6%, both p < 0.001). Anemia and raised NLR were more frequent in the advanced stages of CKD. Logistic regression analysis identified hemoglobin (OR = 0.69, 95% CI: 0.58-0.82, p < 0.001), RDW (OR = 1.78, 95% CI: 1.33-2.39, p = 0.002), and NLR (OR = 1.91, 95% CI: 1.35-2.72, p = 0.001) as independent predictors of advanced CKD. These simple and inexpensive biomarkers are particularly valuable in resource-limited settings.
CONCLUSION: Hematological biomarkers, especially hemoglobin, NLR, and RDW, were effectively used to predict the progression of CKD.